SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of ...

The bureau “may recommend suing drug manufacturers” in the future, the FTC said. Insulin, a hormone produced by the pancreas, helps the body control blood-sugar levels. For people with diabetes, a ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...

Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, ...

A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced ...

Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...

Pfizer Inc.’s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, ...

While these drugs are essential for managing certain conditions, their potential side effects on heart health need careful ...